Control of oxidative stress and reduction in biochemical markers by Vitamin E treatment in patients with nonalcoholic steatohepatitis: A pilot study

Hepatology Research

Volumn 29, Issue 1, 2004, Pages 39-41

  Kawanaka, Miwa ^a   Mahmood, Sabina ^a   Niiyama, Gouichi ^a   Izumi, Akiyoshi ^a   Kamei, Ayumi ^a   Ikeda, Hideji ^a   Suehiro, Mitsuhiko ^a   Togawa, Kazumi ^a   Sasagawa, Takayo ^b   Okita, Misako ^b   Nakamura, Hajime ^c   Yodoi, Junji ^d   Yamada, Gotaro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; BIOCHEMICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOREDOXIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER EXAMINATION; MALE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; STUDENT T TEST; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; WILCOXON SIGNED RANKS TEST;

EID: 2342646130     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.02.002     Document Type: Article

References (18)

1. Ludwig J. Viggiano T.R. McGill D.B. Ott B.J. Nonalcoholic steatohepatitis Mayo Clin. Proc. 55 1980 434-438
2. Weltman M.D. Farrell G.C. Hall P. Ingelmann-Sundberg M. Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with non-alcoholic steatohepatitis Hepatology 27 1998 128-133
3. Younossi Z.M. Diehl A.M. Ong J.P. Nonalcholic fatty liver disease: an agenda for clinical research Hepatology 35 2002 746-752
4. Sumida Y. Nakashima T. Yoh T. Furutani M. Hirohama A. Kakisaka Y. et al. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease J. Hepatol. 38 2003 32-38
5. Chitturi S. Farrell G.C. Etiopathogenesis of nonalcholic steatohepatitis Semin. Liver Dis. 21 2001 27-41
6. Laurin J. Lindor K.D. Crippin J.S. Gossard G.J. Ludwig J. Rakela J. et al. Ursodeoxycholic acid or clofibrate in the treatment of non alcoholic induced steatohepatitis: a pilot study Hepatology 23 1996 1464-1467
7. Lavine J.E. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study J. Pediatr. 136 2000 734-738
8. Brunt E.M. Janney C.G. Di Bisceglie A.M. Neuschwander-Tetri B.A. Bacon B.R. Nonalcholic steatohepatitis: a proposal for grading and staging the histological lesions Am. J. Gastroenterol. 94 1999 2467-2474
9. Kawanaka M. Niiyama G. Mahomood S. Ifukube S. Yoshida N. Onishi H. et al. Effect of TT virus co-infection on interferon response in chronic hepatitis C patients Liver 22 2002 351-355
10. Nakamura H. De Rossa S. Roederer M. Anderson M.T. Dubs J.G. Yodoi J. Elevation of plasma thioredoxin levels in HIV-infected individuals Int. Immunol. 8 1996 603-611
11. Nakamura H. Bai J. Nishinaka Y. Ueda S. Sasada T. Ohshio G. Expression of thioredoxin and gulutaredoxin redox-regulating proteins in pancreatic cancer Cancer Detect. Prev. 24 2000 53-60
12. Yapi K. A simple fluorometric assay for lipidperoxide in blood plasma Biochem. Med. 15 1976 212-216
13. Milan D.B. Botnen J. Retional, α-tochopherol, lycopen, and α- and β- carotene simultaneously determined in plasma by isocratic liquid chromatograpy Clin. Chem. 32 1986 874-876
14. Okita M. Hayashi M. Sasagawa T. Takagi K. Suzuki K. Kinoyama S. et al. Effect of moderately energy restricted diet on obese patients with fatty liver Nutrition 17 2001 542-547
15. Harrison S.A. Ramrakhiani S. Brunt E.M. Arbari M.A. Cortese C. Bacon B.R. Orlistat in the treatment of NASH Am. J. Gastroenterol. 98 2003 926-930
16. Abdelmalek M.F. Angulo P. Jorgensen R.A. Sylvestre P.B. Linder K.D. Betain, a promising new agent for patients with non alcoholic steatohepatitis: result of a pilot study Am. J. Gastroenterol. 96 2001 2711-2717
17. Mahmood S. Yamada G. Niiyama G. Kawanaka M. Togawa K. Sho M. et al. Effect of Vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C Free Radic. Res. 37 2003 781-785
18. Hasegawa T. Yoneda M. Nakamura K. Makino I. Terano A. Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non alcoholic steatohepatitis: a pilot study Aliment. Pharmacol. Ther. 15 2001 1667-1672